HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xun Xu Selected Research

Ribose-Phosphate Pyrophosphokinase (Phosphoribosyl Pyrophosphate Synthetase)

6/2015The expanding spectrum of PRPS1-associated phenotypes: three novel mutations segregating with X-linked hearing loss and mild peripheral neuropathy.
12/2014Expanding the phenotype of PRPS1 syndromes in females: neuropathy, hearing loss and retinopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xun Xu Research Topics

Disease

46Diabetic Retinopathy (Retinopathy, Diabetic)
08/2021 - 12/2002
33Neoplasms (Cancer)
11/2022 - 02/2009
21Inflammation (Inflammations)
01/2021 - 09/2004
19Infections
01/2022 - 05/2002
14Myopia
11/2022 - 07/2011
12Ganglion Cysts (Ganglion)
01/2022 - 05/2003
12Macular Edema
01/2020 - 11/2009
12Retinal Detachment (Retinal Detachments)
04/2019 - 05/2003
10Macular Degeneration (Age-Related Maculopathy)
06/2022 - 12/2002
9Refractive Errors (Refractive Error)
05/2022 - 01/2006
9Virus Diseases (Viral Diseases)
06/2021 - 01/2005
8Type 2 Diabetes Mellitus (MODY)
08/2021 - 03/2010
8Retinal Neovascularization
01/2021 - 06/2008
8Choroidal Neovascularization
01/2020 - 10/2008
8Hyperglycemia
02/2017 - 05/2008
8Corneal Neovascularization
01/2017 - 02/2007
7Cataract (Cataracts)
08/2021 - 12/2002
7Glaucoma
04/2021 - 10/2011
7Uveitis
12/2019 - 01/2011
6Retinal Perforations
04/2022 - 08/2011
6COVID-19
01/2022 - 01/2020
6Pathologic Neovascularization
12/2020 - 11/2009
5Retinal Vein Occlusion
01/2022 - 10/2013
5Hemorrhage
01/2020 - 08/2008
5Burns
03/2018 - 05/2010
5Vitreous Detachment (Posterior Vitreous Detachment)
01/2012 - 09/2004
5Leukemia
06/2011 - 10/2009
4Atrophy
06/2022 - 01/2021
4Ischemia
01/2021 - 05/2014
4Neoplasm Metastasis (Metastasis)
03/2020 - 06/2010
4Hypoxia (Hypoxemia)
01/2020 - 07/2010
3Astigmatism
01/2022 - 03/2013
3Cytokine Release Syndrome
01/2022 - 01/2021
3Hepatocellular Carcinoma (Hepatoma)
01/2022 - 10/2013
3Disease Resistance
10/2019 - 12/2017
3Retinal Diseases
01/2019 - 01/2012
3Epiretinal Membrane (Epiretinal Membranes)
01/2019 - 11/2006
3Keratitis
11/2017 - 12/2015
3Neovascular Glaucoma
06/2016 - 01/2016
3Deafness (Deaf Mutism)
04/2015 - 12/2014
3Blindness (Hysterical Blindness)
01/2015 - 12/2002

Drug/Important Bio-Agent (IBA)

54Retinaldehyde (Retinal)IBA
01/2022 - 12/2002
29Peptides (Polypeptides)IBA
01/2021 - 02/2007
26Proteins (Proteins, Gene)FDA Link
08/2021 - 05/2002
26Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 04/2004
14Glucose (Dextrose)FDA LinkGeneric
01/2019 - 02/2006
10Pharmaceutical PreparationsIBA
01/2021 - 10/2008
10Reactive Oxygen Species (Oxygen Radicals)IBA
02/2017 - 02/2006
9Ranibizumab (Lucentis)FDA Link
01/2022 - 08/2012
9Messenger RNA (mRNA)IBA
05/2019 - 03/2007
9Bevacizumab (Avastin)FDA Link
01/2019 - 10/2008
7Biomarkers (Surrogate Marker)IBA
01/2022 - 03/2012
7DNA (Deoxyribonucleic Acid)IBA
01/2021 - 01/2013
7Oxygen (Dioxygen)IBA
01/2021 - 06/2011
7CytokinesIBA
01/2020 - 08/2008
7EnzymesIBA
01/2020 - 07/2010
6Mydriatics (Cycloplegics)IBA
11/2022 - 01/2017
6MicroRNAs (MicroRNA)IBA
01/2022 - 05/2014
6KH902 fusion proteinIBA
01/2020 - 09/2014
6AlkaliesIBA
03/2018 - 05/2010
6EndotoxinsIBA
05/2014 - 01/2011
5Antiviral Agents (Antivirals)IBA
01/2022 - 01/2005
5Phosphotransferases (Kinase)IBA
01/2020 - 10/2011
4NucleotidesIBA
05/2022 - 03/2012
4RNA (Ribonucleic Acid)IBA
01/2022 - 01/2015
4Transcription Factors (Transcription Factor)IBA
06/2018 - 07/2010
4Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2017 - 01/2011
4Hyaluronic Acid (Hyaluronan)IBA
07/2015 - 09/2007
4Small Interfering RNA (siRNA)IBA
01/2012 - 04/2010
4AntigensIBA
11/2010 - 10/2009
3Biological ProductsIBA
01/2022 - 01/2012
3Indicators and Reagents (Reagents)IBA
01/2022 - 04/2009
3InterleukinsIBA
01/2022 - 01/2011
3Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2017
3Anti-Bacterial Agents (Antibiotics)IBA
04/2021 - 11/2020
3Fluorescein (Funduscein)FDA LinkGeneric
01/2021 - 06/2009
3Tryptophan (L-Tryptophan)FDA Link
11/2020 - 01/2018
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020 - 01/2011
3Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2020 - 01/2017
3Capsules (Microcapsules)IBA
01/2019 - 02/2016
3Mitomycin (Mitomycin-C)FDA LinkGeneric
01/2019 - 10/2012
3ThrombomodulinIBA
11/2017 - 11/2011
3Neuroprotective AgentsIBA
09/2017 - 08/2014
3Therapeutic UsesIBA
01/2017 - 08/2012
3Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
10/2015 - 02/2013
3pigment epithelium-derived factorIBA
01/2014 - 04/2009
3Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2012 - 04/2007

Therapy/Procedure

26Therapeutics
11/2022 - 07/2008
11Intravitreal Injections
01/2021 - 01/2005
11Lasers (Laser)
01/2020 - 11/2009
7Vitrectomy
04/2022 - 11/2009
6Drug Therapy (Chemotherapy)
01/2021 - 06/2009
6Aftercare (After-Treatment)
05/2019 - 07/2011
5Light Coagulation
01/2020 - 11/2009
5Injections
01/2017 - 01/2014
4Telescopes
05/2022 - 11/2006
4Immunotherapy
01/2022 - 10/2010
4Transplantation
07/2021 - 10/2012
3Traction
06/2022 - 08/2011
3Slit Lamp
03/2010 - 01/2006